After two painfully incremental drug approvals, the Duchenne muscular dystrophy (DMD) field is still searching for a therapy that can substantially improve patients' lives and lifespan.
Enter Exonics Therapeutics and CRISPR/Cas9.
Can CRISPR Bring Real Progress in Duchenne Muscular Dystrophy?
Comment
Show comments
Hide Comments
